Clinical trials
Recruiting Leukemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 15 |
| 2025 | 20 |
| 2026 | 26 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 104 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 9 |
| M.D. Anderson Cancer Center | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| UNC Lineberger Comprehensive Cancer Center | 4 |
| Kura Oncology, Inc. | 3 |
| Massachusetts General Hospital | 3 |
| University of Alabama at Birmingham | 3 |
| University of Chicago | 3 |
| University of Nebraska | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 104 |
| Lymphoma | 34 |
| Leukemia, Myeloid, Acute | 32 |
| Hematologic Neoplasms | 22 |
| Myelodysplastic Syndromes | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Multiple Myeloma | 14 |
| Myeloproliferative Disorders | 12 |
| Lymphoma, Non-Hodgkin | 11 |
| Burkitt Lymphoma | 9 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.